Cart
sales@molnova.com
Benzylideneaniline
CAS No. 538-51-2
Benzylideneaniline( N-Benzylideneaniline )
Catalog No. M27245 CAS No. 538-51-2
Benzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 29 | In Stock |
|
| 5MG | 29 | In Stock |
|
| 10MG | 40 | In Stock |
|
| 25MG | 65 | In Stock |
|
| 50MG | 93 | In Stock |
|
| 100MG | 138 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 299 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBenzylideneaniline
-
NoteResearch use only, not for human use.
-
Brief DescriptionBenzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.
-
DescriptionBenzylideneaniline is a potent inhibitor of lignostilbene-α,β-dioxygenase, a key enzyme in oxidative cleavage of the central double bond of lignostilbene.
-
In Vitro——
-
In Vivo——
-
SynonymsN-Benzylideneaniline
-
PathwayOthers
-
TargetOther Targets
-
RecptorSR-BI
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number538-51-2
-
Formula Weight181.238
-
Molecular FormulaC13H11N
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(=N/c1ccccc1)\c1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Nieland TJ, Shaw JT, Jaipuri FA, Maliga Z, Duffner JL, Koehler AN, Krieger M. Influence of HDL-cholesterol-elevating drugs on the in vitro activity of the HDL receptor SR-BI. J Lipid Res. 2007 Aug;48(8):1832-45. Epub 2007 May 28. PubMed PMID: 17533223.
molnova catalog
related products
-
MBP (90-106), phosph...
MBP (90-106), phosphorylated
-
Presatovir
Presatovir (GS-5806) is a novel, orally bioavailable RSV fusion inhibitor (mean EC50: 0.43 nM).Presatovir exhibits potent activity against a wide range of RSV A and B clinical isolates (mean EC50: 0.43 nM) [1]. GS-5806 inhibits pre to post triggered conformational changes of RSV F protein, suggesting a possible mechanism for antiviral activity.
-
PF-04937319
PF-04937319 is an activator of glucokinase (EC50 =154.4 ?μM). PF-04937319 maintains glucose-lowering efficacy while mitigating the risk of hypoglycemia observed with many other glucokinase activators. PF-04937319 can be used in research on the treatment of type 2 diabetes mellitus.
